Research / PTSD / Study Back to all studies Withdrawn NCT01664260
Efficacy Mechanism of N-acetylcysteine in Patients With PTSD Official study title Elucidation of Efficacy Mechanism of N-acetylcysteine in Patients With Posttraumatic Stress Disorder: An 8-week Multimodal Neuroimaging and Neurocognitive Study
Medication study Ages 20–65 South Korea
Countries South Korea
Status Withdrawn
Registry ClinicalTrials.gov
Study type Drug i A study involving a medication or substance.
Study design Interventional i A study where researchers assign a treatment, tool, therapy, procedure, or program.
Age eligibility From 20 Years to 65 Years
Sponsor Ewha Womans University The study in practice Understand this study Who could participate? Listed age limits: 20 years to 65 years.
ActivitiesMedication described in the protocol · Placebo comparator CompensationPayment and expense reimbursement have not been verified. What to know before participating A point to clarify This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Study clarity Things to check before joining Study start date Estimated: November 1, 2012
Recruitment status Withdrawn
Enrollment listed in the registry 0
Sponsor Ewha Womans University
Sponsor type University
Study type Drug
Intervention type Medication / drug
Study phase Phase 2 i Usually explores whether the intervention may work, while continuing to monitor safety.
Locations South Korea
Age range From 20 Years to 65 Years
Official registry ID NCT01664260 Ask HopeStage to help me review this study This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: NCT01664260. We help you review the study, but cannot decide medical eligibility.
A listed location does not confirm current availability.
FAQ Questions about this study Who is behind this study? The study sponsor is Ewha Womans University, a university.
Does this study involve medication? Yes. The study involves medication, including N-acetylcysteine and Placebo.
Who can participate? Listed age limits: 20 years to 65 years.
Is this study still recruiting? The registry lists this study as withdrawn.
Explore other studies Want to find a study that may fit you better? Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me